OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Serology of Lupus Erythematosus: Correlation between Immunopathological Features and Clinical Aspects
Emanuele Cozzani, Massimo Drosera, Giulia Gasparini, et al.
Autoimmune Diseases (2014) Vol. 2014, pp. 1-13
Open Access | Times Cited: 174
Emanuele Cozzani, Massimo Drosera, Giulia Gasparini, et al.
Autoimmune Diseases (2014) Vol. 2014, pp. 1-13
Open Access | Times Cited: 174
Showing 1-25 of 174 citing articles:
IL-21 drives expansion and plasma cell differentiation of autoreactive CD11chiT-bet+ B cells in SLE
Shu Wang, Jingya Wang, Varsha Kumar, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 456
Shu Wang, Jingya Wang, Varsha Kumar, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 456
The Diagnosis and Treatment of Systemic Lupus Erythematosus
Annegret Kuhn, Gisela Bonsmann, Hans‐Joachim Anders, et al.
Deutsches Ärzteblatt international (2015)
Open Access | Times Cited: 214
Annegret Kuhn, Gisela Bonsmann, Hans‐Joachim Anders, et al.
Deutsches Ärzteblatt international (2015)
Open Access | Times Cited: 214
Autoantibodies in SLE: Specificities, Isotypes and Receptors
Bárbara Dema, Nicolas Charles
Antibodies (2016) Vol. 5, Iss. 1, pp. 2-2
Open Access | Times Cited: 160
Bárbara Dema, Nicolas Charles
Antibodies (2016) Vol. 5, Iss. 1, pp. 2-2
Open Access | Times Cited: 160
GAD65 neurological autoimmunity
Andrew McKeon, Jennifer A. Tracy
Muscle & Nerve (2017) Vol. 56, Iss. 1, pp. 15-27
Closed Access | Times Cited: 158
Andrew McKeon, Jennifer A. Tracy
Muscle & Nerve (2017) Vol. 56, Iss. 1, pp. 15-27
Closed Access | Times Cited: 158
Differential diagnosis of multiple sclerosis and other inflammatory CNS diseases
Paula Wildner, Mariusz Stasiołek, Mariola Matysiak
Multiple Sclerosis and Related Disorders (2019) Vol. 37, pp. 101452-101452
Open Access | Times Cited: 85
Paula Wildner, Mariusz Stasiołek, Mariola Matysiak
Multiple Sclerosis and Related Disorders (2019) Vol. 37, pp. 101452-101452
Open Access | Times Cited: 85
<p>Sjögren's syndrome and systemic lupus erythematosus: links and risks</p>
Sandra Gofinet Pasoto, Victor Adriano de Oliveira Martins, Eloísa Bonfá
Open Access Rheumatology Research and Reviews (2019) Vol. Volume 11, pp. 33-45
Open Access | Times Cited: 81
Sandra Gofinet Pasoto, Victor Adriano de Oliveira Martins, Eloísa Bonfá
Open Access Rheumatology Research and Reviews (2019) Vol. Volume 11, pp. 33-45
Open Access | Times Cited: 81
Choosing wisely: Review and commentary on anti-nuclear antibody (ANA) testing
Marvin J. Fritzler
Autoimmunity Reviews (2015) Vol. 15, Iss. 3, pp. 272-280
Closed Access | Times Cited: 73
Marvin J. Fritzler
Autoimmunity Reviews (2015) Vol. 15, Iss. 3, pp. 272-280
Closed Access | Times Cited: 73
Systemic Lupus Erythematosus with and without Anti‐dsDNA Antibodies: Analysis from a Large Monocentric Cohort
Fabrizio Conti, Fulvia Ceccarelli, Carlo Perricone, et al.
Mediators of Inflammation (2015) Vol. 2015, Iss. 1
Open Access | Times Cited: 71
Fabrizio Conti, Fulvia Ceccarelli, Carlo Perricone, et al.
Mediators of Inflammation (2015) Vol. 2015, Iss. 1
Open Access | Times Cited: 71
Biomarkers in rheumatic diseases: how can they facilitate diagnosis and assessment of disease activity?
Chandra Mohan, Shervin Assassi
BMJ (2015), pp. h5079-h5079
Open Access | Times Cited: 70
Chandra Mohan, Shervin Assassi
BMJ (2015), pp. h5079-h5079
Open Access | Times Cited: 70
T-bet+CD11c+ B cells are critical for antichromatin immunoglobulin G production in the development of lupus
Liu Ya, Shiyu Zhou, Jie Qian, et al.
Arthritis Research & Therapy (2017) Vol. 19, Iss. 1
Open Access | Times Cited: 68
Liu Ya, Shiyu Zhou, Jie Qian, et al.
Arthritis Research & Therapy (2017) Vol. 19, Iss. 1
Open Access | Times Cited: 68
New treatments for inflammatory rheumatic disease
Carlo Selmi, Elena Generali, Marco Massarotti, et al.
Immunologic Research (2014) Vol. 60, Iss. 2-3, pp. 277-288
Closed Access | Times Cited: 57
Carlo Selmi, Elena Generali, Marco Massarotti, et al.
Immunologic Research (2014) Vol. 60, Iss. 2-3, pp. 277-288
Closed Access | Times Cited: 57
Anti-RO/SSA and anti-La/SSB antibodies: Association with mild lupus manifestations in 645 childhood-onset systemic lupus erythematosus
Gláucia V. Novak, Mariana Correia Marques, Verena Andrade Balbi, et al.
Autoimmunity Reviews (2016) Vol. 16, Iss. 2, pp. 132-135
Closed Access | Times Cited: 57
Gláucia V. Novak, Mariana Correia Marques, Verena Andrade Balbi, et al.
Autoimmunity Reviews (2016) Vol. 16, Iss. 2, pp. 132-135
Closed Access | Times Cited: 57
Translating epigenetics into clinic: focus on lupus
Zijun Wang, Christopher Chang, Mou Peng, et al.
Clinical Epigenetics (2017) Vol. 9, Iss. 1
Open Access | Times Cited: 51
Zijun Wang, Christopher Chang, Mou Peng, et al.
Clinical Epigenetics (2017) Vol. 9, Iss. 1
Open Access | Times Cited: 51
The impact of anti-U1-RNP positivity: systemic lupus erythematosus versus mixed connective tissue disease
Alina Dima, Ciprian Jurcuț, Cristian Băicuş
Rheumatology International (2018) Vol. 38, Iss. 7, pp. 1169-1178
Closed Access | Times Cited: 51
Alina Dima, Ciprian Jurcuț, Cristian Băicuş
Rheumatology International (2018) Vol. 38, Iss. 7, pp. 1169-1178
Closed Access | Times Cited: 51
TGF-β Pathway in Salivary Gland Fibrosis
Xianglan Zhang, Jun Seop Yun, Dawool Han, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 23, pp. 9138-9138
Open Access | Times Cited: 43
Xianglan Zhang, Jun Seop Yun, Dawool Han, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 23, pp. 9138-9138
Open Access | Times Cited: 43
Functional Genomics Using High‐Throughput Methods for Salivary Analysis in Sjögren's Disease
Giovanna Piacenza Florezi, Mônica Teresa Veneziano Labate, Carlos Alberto Labate, et al.
Oral Diseases (2025)
Open Access
Giovanna Piacenza Florezi, Mônica Teresa Veneziano Labate, Carlos Alberto Labate, et al.
Oral Diseases (2025)
Open Access
Clinical significance of anti-Ro and Anti-La antibodies: The role of isolated anti-La
Clara Sangüesa Gómez, Alejandro Olivé, Íñigo Rúa‐Figueroa, et al.
Lupus (2025)
Closed Access
Clara Sangüesa Gómez, Alejandro Olivé, Íñigo Rúa‐Figueroa, et al.
Lupus (2025)
Closed Access
Biomarkers in connective tissue diseases
Neelakshi R. Jog, Judith A. James
Journal of Allergy and Clinical Immunology (2017) Vol. 140, Iss. 6, pp. 1473-1483
Open Access | Times Cited: 47
Neelakshi R. Jog, Judith A. James
Journal of Allergy and Clinical Immunology (2017) Vol. 140, Iss. 6, pp. 1473-1483
Open Access | Times Cited: 47
Systemic lupus erythematosus: nothing stale her infinite variety
Kenji Oku, Tatsuya Atsumi
Modern Rheumatology (2018) Vol. 28, Iss. 5, pp. 758-765
Closed Access | Times Cited: 46
Kenji Oku, Tatsuya Atsumi
Modern Rheumatology (2018) Vol. 28, Iss. 5, pp. 758-765
Closed Access | Times Cited: 46
Autoantibodies targeting glomerular annexin A2 identify patients with proliferative lupus nephritis
Dawn J. Caster, Erik A. Korte, Michael L. Merchant, et al.
PROTEOMICS - CLINICAL APPLICATIONS (2015) Vol. 9, Iss. 11-12, pp. 1012-1020
Open Access | Times Cited: 42
Dawn J. Caster, Erik A. Korte, Michael L. Merchant, et al.
PROTEOMICS - CLINICAL APPLICATIONS (2015) Vol. 9, Iss. 11-12, pp. 1012-1020
Open Access | Times Cited: 42
Antibodies targeting circulating protective molecules in lupus nephritis: Interest as serological biomarkers
Chantal Dumestre‐Pérard, Giovanna Clavarino, Sophie Colliard, et al.
Autoimmunity Reviews (2018) Vol. 17, Iss. 9, pp. 890-899
Open Access | Times Cited: 39
Chantal Dumestre‐Pérard, Giovanna Clavarino, Sophie Colliard, et al.
Autoimmunity Reviews (2018) Vol. 17, Iss. 9, pp. 890-899
Open Access | Times Cited: 39
Neurologic Complications of Systemic Lupus Erythematosus, Sjögren Syndrome, and Rheumatoid Arthritis
Simon M. Helfgott, Shamik Bhattacharyya
Seminars in Neurology (2014) Vol. 34, Iss. 04, pp. 425-436
Closed Access | Times Cited: 41
Simon M. Helfgott, Shamik Bhattacharyya
Seminars in Neurology (2014) Vol. 34, Iss. 04, pp. 425-436
Closed Access | Times Cited: 41
Systemic manifestations of primary Sjögren's syndrome in the NOD.B10Sn-H2/J mouse model
Jeremy Kiripolsky, Long Shen, Yichen Liang, et al.
Clinical Immunology (2017) Vol. 183, pp. 225-232
Open Access | Times Cited: 35
Jeremy Kiripolsky, Long Shen, Yichen Liang, et al.
Clinical Immunology (2017) Vol. 183, pp. 225-232
Open Access | Times Cited: 35
Cutaneous characteristics and association with antinuclear antibodies in 402 patients with different subtypes of lupus erythematosus
Nikolaos Patsinakidis, Thilo Gambichler, Nina Lahner, et al.
Journal of the European Academy of Dermatology and Venereology (2016) Vol. 30, Iss. 12, pp. 2097-2104
Closed Access | Times Cited: 32
Nikolaos Patsinakidis, Thilo Gambichler, Nina Lahner, et al.
Journal of the European Academy of Dermatology and Venereology (2016) Vol. 30, Iss. 12, pp. 2097-2104
Closed Access | Times Cited: 32
Type I interferon gene signature test–low and –high patients with systemic lupus erythematosus have distinct gene expression signatures
PZ Brohawn, Katie Streicher, Brandon W. Higgs, et al.
Lupus (2019) Vol. 28, Iss. 13, pp. 1524-1533
Closed Access | Times Cited: 32
PZ Brohawn, Katie Streicher, Brandon W. Higgs, et al.
Lupus (2019) Vol. 28, Iss. 13, pp. 1524-1533
Closed Access | Times Cited: 32
